• 20(S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3
• A 4-gene prognostic index for enhancing acute myeloid leukaemia survival prediction
• A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy
• A complex t(15;22;17)(q22;q11.2;q21) variant of APL
• A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid sarcoma of the spine
• A Rare Cause of Pancytopenia in Systemic Lupus Erythematosus (SLE) in a Young Patient
• A rare incidence of severe dermatological toxicities triggered by concomitant administration of all-trans retinoic acid and triazole antifungal in patients with acute promyelocytic leukemia: a case series and review of the literature
• A Sole p.G391E Mutation in PML::RARA Identified in Relapsed Acute Promyelocytic Leukemia
• Acute effects of atrazine on the immunoexpressions of sertoli and germ cells molecular markers, cytokines, chemokines, and sex hormones levels in mice testes and epididymides
• Acute Promyelocytic Leukemia
• Acute promyelocytic leukemia in children cancer hospital Egypt
• Acute promyelocytic leukemia with additional chromosome abnormalities in a patient positive for HIV: A case report and literature review
• Acute Promyelocytic Leukemia With Long and Short Isoforms of PML::RARA Fusion Transcripts Complicated by Abdominal Distension and Acute Edematous Pancreatitis During Induction Treatment: A Case Report
• Acute promyelocytic leukemia with torque teno mini virus (TTMV)::RARA fusion: an approach to screening and diagnosis
• Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL-60 cells
• All trans retinoic acid-induced bilateral disc edema in a case of acute promyelocytic leukemia
• All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia
• Alteration of Hepatic Cytochrome P450 Expression and Arachidonic Acid Metabolism by Arsenic Trioxide (ATO) in C57BL/6 Mice
• Analysis of the occurrence and liver function characteristics of arsenic-associated liver injury during the treatment of pediatric patients with acute promyelocytic leukemia
• Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKalpha-JNK pathway
• Arsenic trioxide regulates the glycolytic pathway to treat acute promyelocytic leukemia by inhibiting RPL22L1
• Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia
• ATPR induces acute promyelocytic leukemia cells differentiation and cycle arrest via the lncRNA CONCR/DDX11/PML-RARalpha signaling axis
• Atypical Differentiation Syndrome with Sudden Vision Loss in Acute Promyelocytic Leukemia Treated with ATRA plus ATO: a Clinical Case
• Biochemical risk factors and outcomes of acute promyelocytic leukemia patients with thrombotic events: a matched pair analysis
• Biologic and clinical characteristics of isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia
• Causes and risk factors for early death in adult patients with acute promyelocytic leukemia: a real-life experience
• Central venous catheters do not increase the hemorrhagic risk in acute promyelocytic leukemia patients during induction therapy
• Characteristics and complications of acute promyelocytic leukemia in children: an analysis of a national database
• Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?
• Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?
• Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single-centre retrospective study
• Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
• Combination Effect of Deferoxamine and Arsenic Trioxide on Viability and Vitality of APL Like Cell Line
• CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
• Critical Role of Tripartite Fusion and LBD Truncation in Certain RARA- and all RARG-Related Atypical APL
• Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia
• Design, <em>in silico</em> Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase
• Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
• Differentiation syndrome in acute promyelocytic leukemia: A leopard cannot change its spots
• Double Emergency: A Case of Concurrent Heparin-Induced Thrombocytopenia and Acute Promyelocytic Leukemia
• Early mortality in acute promyelocytic leukemia - a single center experience
• Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide
• Effect of Shikonin on Autophagy and Apoptosis of Human Promyelocytic Leukemia Cells
• Efficacy of Decitabine Combined with Preexcitation Regimen in Treatment of Newly Diagnosed AML Patients Who Did not Respond to Initial Standard Induction Chemotherapy
• Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes
• Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
• Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
• Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemia
• Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells
• Function of PML-RARA in Acute Promyelocytic Leukemia
• Guiding the Management of Acute Promyelocytic Leukemia: A Quality Improvement Project
• Halogenated retinoid derivatives as dual RARalpha and RXRalpha modulators for treating acute promyelocytic leukemia cells
• Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial
• Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery
• Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus
• Higher TIGIT+ gammadelta T(CM) cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML
• Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF
• History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies
• How I Treat: Differentiation Therapy in Acute Myeloid Leukemia
• Identification of a Novel MAPK1::BCR Fusion Gene/t(9;22)(q34;q11) in a Patient with Acute Promyelocytic Leukemia
• Identification of triciribine as a novel myeloid cell differentiation inducer
• Identifying Differential Methylation in Cancer Epigenetics via a Bayesian Functional Regression Model
• Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia
• Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia
• Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia
• JSH practical guidelines for hematological malignancies, 2023: leukemia-2-acute promyelocytic leukemia (APL)
• Malformation of the endoplasmic reticulum system evolving into giant inclusions and Auer bodies in acute promyelocytic leukemia: an ultrastructural study of 6 cases
• Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy
• Measurable Residual Disease Analysis by Flow Cytometry and Correlation With Molecular Measurable Residual Disease in Acute Promyelocytic Leukemia: A Real-World Prospective Study
• Microgranular Acute Promyelocytic Leukemia in a Patient with Down Syndrome
• Middle Meningeal Artery Embolization in Acute Leukemia Patients Presenting With Subdural Hematoma
• Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ
• Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies
• Mortality Audit of Cancer Patients in the Department of Medical Oncology at a Tertiary Cancer Care Centre in South India
• Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells
• National study reveals gram negative bacteremia on contemporary pediatric AML protocol
• Negative expression of CD117 predicted inferior OS and PFS in acute promyelocytic leukemia
• Oridonin, a small molecule inhibitor of cancer stem cell with potent cytotoxicity and differentiation potential
• Outcomes of Acute Promyelocytic Leukaemia in Paediatric Patients: Insights from a Low-Middle-Income Country
• Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment
• Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review
• Phase separation of PML/RARalpha and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia
• PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells
• Pseudotumor Cerebri Secondary to All-Trans Retinoic Acid/Arsenic Trioxide Therapy in Acute Promyelocytic Leukemia: A Case Report and Review of the Literature
• Rapid screening of acute promyelocytic leukaemia in daily batch specimens: A novel artificial intelligence-enabled approach to bone marrow morphology
• SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia
• Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARalpha fusion gene: a case report and literature review
• Successful remission induction with reduced-dose all-trans retinoic acid for acute promyelocytic leukemia complicated by COVID-19
• Surgical treatment of appendiceal mucormycosis in an immunocompromised patient: a case report
• The Importance of Rapid Laboratory Diagnosis of Acute Promyelocytic Leukemia
• The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients
• The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes
• Three-Way Translocation t(12;15;17) (p13;q24;q21) Found in Acute Promyelocytic Leukemia with Basophilic Differentiation
• Thrombosis in Myeloid Malignancies, from CHIP to AML
• Tongue cancer developing after haematopoietic stem cell transplantation for treatment of acute promyelocytic leukaemia: A case report
• Treatment of a Patient with Acute Promyelocytic Leukemia with Multiple Isolated Relapses in the Central Nervous System: A Case Report and Mini-Review of the Literature
• Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy
• Tricarbonyl rhenium(i) complexes with 8-hydroxyquinolines: structural, chemical, antibacterial, and anticancer characteristics
• When acute promyelocytic leukaemia changes its face in the peripheral blood